Resveratrol attenuates oxidative stress in mitochondrial Complex i deficiency: Involvement of SIRT3

Free Radical Biology and Medicine

Volumn 96, Issue , 2016, Pages 190-198

  Mathieu, Lise ^a   Costa, Alexandra Lopes ^a   Le Bachelier, Carole ^a   Slama, Abdelhamid ^b   Lebre, Anne Sophie ^c   Taylor, Robert W ^d   Bastin, Jean ^a   Djouadi, Fatima ^a  

^a INSERM   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c HÔPITAL MAISON BLANCHE   (France)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Complex I deficiency; Mitochondrial diseases; Oxidative stress; Pharmacological therapy; Resveratrol; SIRT3; SOD2

Indexed keywords

ANTIOXIDANT; CELL PROTEIN; ESTROGEN RECEPTOR; ESTROGEN RELATED RECEPTOR ALPHA; MANGANESE SUPEROXIDE DISMUTASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RESVERATROL; SIRTUIN 3; SMALL INTERFERING RNA; ERRALPHA ESTROGEN-RELATED RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN; SIRT3 PROTEIN, HUMAN; STILBENE DERIVATIVE; SUPEROXIDE DISMUTASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; FIBROBLAST; HUMAN; HUMAN CELL; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; CELL CULTURE; DEFICIENCY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MITOCHONDRION;

ANTIOXIDANTS; CELLS, CULTURED; ELECTRON TRANSPORT COMPLEX I; ESTROGEN RECEPTOR ALPHA; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; OXIDATIVE STRESS; OXYGEN CONSUMPTION; REACTIVE OXYGEN SPECIES; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; SIRTUIN 3; STILBENES; SUPEROXIDE DISMUTASE;

EID: 84964573495     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.04.027     Document Type: Article

References (43)

1. E.J. Tucker, A.G. Compton, S.E. Calvo, and D.R. Thorburn The molecular basis of human complex I deficiency IUBMB Life 63 2011 669 677
2. F. Distelmaier, W.J. Koopman, L.P. van den Heuvel, R.J. Rodenburg, E. Mayatepek, P.H. Willems, and J.A. Smeitink Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease Brain: J. Neurol. 132 2009 833 842
3. S. Papa, and D. De Rasmo Complex I deficiencies in neurological disorders Trends Mol. Med. 19 2013 61 69
4. T.B. Haack, B. Haberberger, E.M. Frisch, T. Wieland, A. Iuso, M. Gorza, V. Strecker, E. Graf, J.A. Mayr, U. Herberg, J.B. Hennermann, T. Klopstock, K.A. Kuhn, U. Ahting, W. Sperl, E. Wilichowski, G.F. Hoffmann, M. Tesarova, H. Hansikova, J. Zeman, B. Plecko, M. Zeviani, I. Wittig, T.M. Strom, M. Schuelke, P. Freisinger, T. Meitinger, and H. Prokisch Molecular diagnosis in mitochondrial complex I deficiency using exome sequencing J. Med. Genet. 49 2012 277 283
5. S. Verkaart, W.J. Koopman, S.E. van Emst-de Vries, L.G. Nijtmans, L.W. van den Heuvel, J.A. Smeitink, and P.H. Willems Superoxide production is inversely related to complex I activity in inherited complex I deficiency Biochim. Biophys. Acta 1772 2007 373 381
6. P. Roestenberg, G.R. Manjeri, F. Valsecchi, J.A. Smeitink, P.H. Willems, and W.J. Koopman Pharmacological targeting of mitochondrial complex I deficiency: the cellular level and beyond Mitochondrion 12 2012 57 65
7. F. Valsecchi, W.J. Koopman, G.R. Manjeri, R.J. Rodenburg, J.A. Smeitink, and P.H. Willems Complex I disorders: causes, mechanisms, and development of treatment strategies at the cellular level Dev. Disabil. Res. Rev. 16 2010 175 182
8. J. Tome-Carneiro, M. Larrosa, A. Gonzalez-Sarrias, F.A. Tomas-Barberan, M.T. Garcia-Conesa, and J.C. Espin Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence Curr. Pharm. Des. 19 2013 6064 6093
9. S.S. Kulkarni, and C. Canto The molecular targets of resveratrol Biochim. Biophys. Acta 1852 2015 1114 1123
10. A. Lopes Costa, C. Le Bachelier, L. Mathieu, A. Rotig, A. Boneh, P. De Lonlay, M.A. Tarnopolsky, D.R. Thorburn, J. Bastin, and F. Djouadi Beneficial effects of resveratrol on respiratory chain defects in patients' fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling Hum. Mol. Genet. 23 2014 2106 2119
11. S. Bastianetto, C. Menard, and R. Quirion Neuroprotective action of resveratrol Biochim. Biophys. Acta 1852 2015 1195 1201
12. A. Giralt, and F. Villarroya SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging Biochem. J. 444 2012 1 10
13. Y. Chen, J. Zhang, Y. Lin, Q. Lei, K.L. Guan, S. Zhao, and Y. Xiong Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS EMBO Rep. 12 2011 534 541
14. X. Qiu, K. Brown, M.D. Hirschey, E. Verdin, and D. Chen Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation Cell Metab. 12 2010 662 667
15. R. Tao, M.C. Coleman, J.D. Pennington, O. Ozden, S.H. Park, H. Jiang, H.S. Kim, C.R. Flynn, S. Hill, W. Hayes McDonald, A.K. Olivier, D.R. Spitz, and D. Gius Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress Mol. Cell 40 2010 893 904
16. C. Aguer, D. Gambarotta, R.J. Mailloux, C. Moffat, R. Dent, R. McPherson, and M.E. Harper Galactose enhances oxidative metabolism and reveals mitochondrial dysfunction in human primary muscle cells PloS One 6 2011 e28536
17. A. Golubitzky, P. Dan, S. Weissman, G. Link, J.D. Wikstrom, and A. Saada Screening for active small molecules in mitochondrial complex I deficient patient's fibroblasts, reveals AICAR as the most beneficial compound PloS One 6 2011 e26883
18. A.J. Janssen, F.J. Trijbels, R.C. Sengers, J.A. Smeitink, L.P. van den Heuvel, L.T. Wintjes, B.J. Stoltenborg-Hogenkamp, and R.J. Rodenburg Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts Clin. Chem. 53 2007 729 734
19. F. Paoletti, and A. Mocali Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation Methods Enzymol. 186 1990 209 220
20. F. Caruso, J. Tanski, A. Villegas-Estrada, and M. Rossi Structural basis for antioxidant activity of trans-resveratrol: ab initio calculations and crystal and molecular structure J. Agric. Food Chem. 52 2004 7279 7285
21. M. Fukui, H.J. Choi, and B.T. Zhu Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death Free Radic. Biol. Med. 49 2010 800 813
22. E.L. Robb, and J.A. Stuart Resveratrol interacts with estrogen receptor-beta to inhibit cell replicative growth and enhance stress resistance by upregulating mitochondrial superoxide dismutase Free Radic. Biol. Med. 50 2011 821 831
23. E.L. Robb, and J.A. Stuart The stilbenes resveratrol, pterostilbene and piceid affect growth and stress resistance in mammalian cells via a mechanism requiring estrogen receptor beta and the induction of Mn-superoxide dismutase Phytochemistry 98 2014 164 173
24. E.L. Robb, L. Winkelmolen, N. Visanji, J. Brotchie, and J.A. Stuart Dietary resveratrol administration increases MnSOD expression and activity in mouse brain Biochem. Biophys. Res. Commun. 372 2008 254 259
25. G. Deblois, J.A. Hall, M.C. Perry, J. Laganiere, M. Ghahremani, M. Park, M. Hallett, and V. Giguere Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity Cancer Res. 69 2009 6149 6157
26. L.R. Stein, and S. Imai The dynamic regulation of NAD metabolism in mitochondria Trends Endocrinol. Metab. 23 2012 420 428
27. R. Cerutti, E. Pirinen, C. Lamperti, S. Marchet, A.A. Sauve, W. Li, V. Leoni, E.A. Schon, F. Dantzer, J. Auwerx, C. Viscomi, and M. Zeviani NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease Cell Metab. 19 2014 1042 1049
28. R. Felici, A. Lapucci, L. Cavone, S. Pratesi, R. Berlinguer-Palmini, and A. Chiarugi Pharmacological NAD-boosting strategies improve mitochondrial homeostasis in human complex I-Mutant fibroblasts Mol. Pharmacol. 87 2015 965 971
29. N.A. Khan, M. Auranen, I. Paetau, E. Pirinen, L. Euro, S. Forsstrom, L. Pasila, V. Velagapudi, C.J. Carroll, J. Auwerx, and A. Suomalainen Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3 EBO Mol. Med. 6 2014 721 731
30. C. Canto, K.J. Menzies, and J. Auwerx NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus Cell Metab. 22 2015 31 53
31. L. Mouchiroud, R.H. Houtkooper, and J. Auwerx NAD(+) metabolism: a therapeutic target for age-related metabolic disease Crit. Rev. Biochem. Mol. Biol. 48 2013 397 408
32. E. Pirinen, C. Canto, Y.S. Jo, L. Morato, H. Zhang, K.J. Menzies, E.G. Williams, L. Mouchiroud, N. Moullan, C. Hagberg, W. Li, S. Timmers, R. Imhof, J. Verbeek, A. Pujol, B. van Loon, C. Viscomi, M. Zeviani, P. Schrauwen, A.A. Sauve, K. Schoonjans, and J. Auwerx Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle Cell Metab. 19 2014 1034 1041
33. R.H. Houtkooper, C. Canto, R.J. Wanders, and J. Auwerx The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways Endocr. Rev. 31 2010 194 223
34. Y. Chen, L.L. Fu, X. Wen, X.Y. Wang, J. Liu, Y. Cheng, and J. Huang Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer Cell Death Dis. 5 2014 e1047
35. Y.T. Wu, S.B. Wu, and Y.H. Wei Roles of sirtuins in the regulation of antioxidant defense and bioenergetic function of mitochondria under oxidative stress Free Radic. Res. 48 2014 1070 1084
36. X. Kong, R. Wang, Y. Xue, X. Liu, H. Zhang, Y. Chen, F. Fang, and Y. Chang Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis PloS One 5 2010 e11707
37. R.K. Chaturvedi, and M.F. Beal Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases Mol. Cell. Neurosci. 55 2013 101 114
38. G.N. Breningstall, J. Shoffner, and R.J. Patterson Siblings with leukoencephalopathy Semin. Pediatr. Neurol. 15 2008 212 215
39. H. Pagniez-Mammeri, A. Lombes, M. Brivet, H. Ogier-de Baulny, P. Landrieu, A. Legrand, and A. Slama Rapid screening for nuclear genes mutations in isolated respiratory chain complex I defects Mol. Genet. Metab. 96 2009 196 200
40. H.A. Tuppen, V.E. Hogan, L. He, E.L. Blakely, L. Worgan, M. Al-Dosary, G. Saretzki, C.L. Alston, A.A. Morris, M. Clarke, S. Jones, A.M. Devlin, S. Mansour, Z.M. Chrzanowska-Lightowlers, D.R. Thorburn, R. McFarland, and R.W. Taylor The p.M292T NDUFS2 mutation causes complex I-deficient Leigh syndrome in multiple families Brain: J. Neurol. 133 2010 2952 2963
41. Z. Assouline, M. Jambou, M. Rio, C. Bole-Feysot, P. de Lonlay, C. Barnerias, I. Desguerre, C. Bonnemains, C. Guillermet, J. Steffann, A. Munnich, J.P. Bonnefont, A. Rotig, and A.S. Lebre A constant and similar assembly defect of mitochondrial respiratory chain complex I allows rapid identification of NDUFS4 mutations in patients with Leigh syndrome Biochim. BIophys. Acta 1822 2012 1062 1069
42. S. Lebon, L. Minai, D. Chretien, J. Corcos, V. Serre, N. Kadhom, J. Steffann, J.Y. Pauchard, A. Munnich, J.P. Bonnefont, and A. Rotig A novel mutation of the NDUFS7 gene leads to activation of a cryptic exon and impaired assembly of mitochondrial complex I in a patient with Leigh syndrome Mol. Genet. Metab. 92 2007 104 108
43. S. Lebon, D. Rodriguez, D. Bridoux, A. Zerrad, A. Rotig, A. Munnich, A. Legrand, and A. Slama A novel mutation in the human complex I NDUFS7 subunit associated with Leigh syndrome Mol. Genet. Metab. 90 2007 379 382